Hainan Poly Pharm. Co., Ltd
SZSE:300630 Stock Report
Hainan Poly Pharm Dividends and Buybacks
Dividend criteria checks 0/6 Hainan Poly Pharm does not currently pay a dividend.
Key information Total Shareholder Yield 0.6% Future Dividend Yield 0% Dividend Growth n/a Next dividend pay date n/a Ex dividend date n/a Dividend per share CN¥0.0787 Payout ratio 0%
Recent dividend and buyback updates
Hainan Poly Pharm. Co., Ltd Announces Dividend Implementation of Cash Dividend for 2022, Payable on 18 July 2023 Jul 12
Hainan Poly Pharm. Co., Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 13, 2022 Jul 07
Hainan Poly Pharm. Co., Ltd Approves Cash Dividend for the Year 2021 May 19
Hainan Poly Pharm. Co.,Ltd Proposes Profit Distribution for 2021 Apr 27
Hainan Poly Pharm. Co., Ltd. (SZSE:300630) announces an Equity Buyback for CNY 10 million worth of its shares. Feb 11
Hainan Poly Pharm. Co., Ltd. Approves Profit Distribution Proposal for 2020 May 21
Show all updates
Third quarter 2024 earnings released: CN¥0.089 loss per share (vs CN¥0.31 profit in 3Q 2023) Oct 28
What Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 46% Share Price Gain Is Not Telling You Oct 08
Hainan Poly Pharm. Co., Ltd to Report Q3, 2024 Results on Oct 28, 2024 Sep 30
Second quarter 2024 earnings released: CN¥0.29 loss per share (vs CN¥0.30 profit in 2Q 2023) Aug 29
Investor sentiment improves as stock rises 30% Aug 21
Hainan Poly Pharm. Co., Ltd (SZSE:300630) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable Aug 16
Hainan Poly Pharm. Co., Ltd, Annual General Meeting, Aug 23, 2024 Aug 05
Hainan Poly Pharm. Co., Ltd, Annual General Meeting, Aug 23, 2024 Aug 02
Investor sentiment improves as stock rises 21% Aug 02
Investor sentiment deteriorates as stock falls 36% Jul 12
First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.32 in 1Q 2023) Jul 08
High number of new directors Jul 08
Hainan Poly Pharm. Co., Ltd to Report First Half, 2024 Results on Aug 29, 2024 Jun 29
New minor risk - Financial data availability May 11
Investor sentiment deteriorates as stock falls 16% May 03
It's Down 27% But Hainan Poly Pharm. Co., Ltd (SZSE:300630) Could Be Riskier Than It Looks Apr 21
Investor sentiment deteriorates as stock falls 15% Apr 17
Hainan Poly Pharm. Co., Ltd to Report Q1, 2024 Results on Apr 25, 2024 Mar 30
A Piece Of The Puzzle Missing From Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 27% Share Price Climb Mar 06
Investor sentiment deteriorates as stock falls 15% Feb 02
Hainan Poly Pharm. Co., Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024 Dec 29 Hainan Poly Pharm. Co., Ltd(SZSE:300630) dropped from Shenzhen Stock Exchange Component Index
New minor risk - Shareholder dilution Dec 04
Investor sentiment improves as stock rises 56% Oct 31
New minor risk - Earnings quality Oct 29
New major risk - Share price stability Oct 27
New major risk - Financial position Oct 25
Third quarter 2023 earnings released: EPS: CN¥0.31 (vs CN¥0.38 in 3Q 2022) Oct 25
Hainan Poly Pharm. Co., Ltd to Report Q3, 2023 Results on Oct 25, 2023 Sep 30
Second quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.29 in 2Q 2022) Aug 25
Investor sentiment improves as stock rises 18% Aug 14
Hainan Poly Pharm. Co., Ltd Announces Dividend Implementation of Cash Dividend for 2022, Payable on 18 July 2023 Jul 12
First quarter 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.37 in 1Q 2022) Apr 26
Investor sentiment deteriorates as stock falls 17% Apr 18
High number of new directors Nov 16
Third quarter 2022 earnings released: EPS: CN¥0.38 (vs CN¥0.37 in 3Q 2021) Oct 25
Investor sentiment improved over the past week Oct 18
Second quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.29 in 2Q 2021) Aug 31
Hainan Poly Pharm. Co., Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 13, 2022 Jul 07
Investor sentiment improved over the past week Jun 24
Hainan Poly Pharm. Co., Ltd Approves Cash Dividend for the Year 2021 May 19
Hainan Poly Pharm. Co.,Ltd Proposes Profit Distribution for 2021 Apr 27
High number of new directors Apr 27
Full year 2021 earnings: EPS and revenues miss analyst expectations Apr 15
Investor sentiment deteriorated over the past week Apr 13
Hainan Poly Pharm. Co., Ltd. (SZSE:300630) announces an Equity Buyback for CNY 10 million worth of its shares. Feb 11
Third quarter 2021 earnings released: EPS CN¥0.37 (vs CN¥0.29 in 3Q 2020) Oct 26
Investor sentiment improved over the past week Sep 17
Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.18 in 2Q 2020) Aug 10
Hainan Poly Pharm. Co., Ltd. Approves Profit Distribution Proposal for 2020 May 21
Hainan Poly Pharm. Co., Ltd. Announces Final Dividend for the Year 2020 Apr 27
Full year 2020 earnings released: EPS CN¥0.94 (vs CN¥0.72 in FY 2019) Apr 25
New 90-day high: CN¥49.28 Feb 22
New 90-day high: CN¥47.61 Jan 22
New 90-day low: CN¥38.94 Dec 22
Third quarter earnings released Oct 31
Market bids up stock over the past week Oct 12
New 90-day low: CN¥40.41 Sep 24
First half earnings released Aug 27
Hainan Poly Pharm. Co., Ltd. to Report First Half, 2020 Results on Aug 27, 2020 Aug 11
Hainan Poly Pharm. Co., Ltd. announced a financing transaction Jul 17
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 300630's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 300630's dividend payments have been increasing.
Dividend Yield vs Market Hainan Poly Pharm Dividend Yield vs Market
How does 300630 dividend yield compare to the market? Segment Dividend Yield Company (300630) 0% Market Bottom 25% (CN) 0.5% Market Top 25% (CN) 2.1% Industry Average (Pharmaceuticals) 1.6% Analyst forecast (300630) (up to 3 years) 0%
Notable Dividend: Unable to evaluate 300630's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 300630's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: 300630 is not paying a notable dividend for the CN market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 300630 has not reported any payouts.
Discover strong dividend paying companies Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}